CDC orders additional doses of newborn RSV medication 

CDC ORDERS ADDITIONAL DOSES OF NEWBORN RSV MEDICATION FROM SANOFI AND ASTRAZENECA CDC ORDERS ADDITIONAL DOSES OF NEWBORN RSV MEDICATION FROM SANOFI AND ASTRAZENECA

The CDC has ordered additional doses of newborn RSV medication from Sanofi and AstraZeneca. The CDC has ordered additional doses of newborn RSV medication from Sanofi and AstraZeneca.

The medication is being ordered in the face of scarcity. The medication is being ordered in the face of scarcity.

RSV is a common respiratory virus that can be dangerous for infants. RSV is a common respiratory virus that can be dangerous for infants.

The medication is used to prevent RSV in high-risk infants. The medication is used to prevent RSV in high-risk infants.

The additional doses will help ensure that high-risk infants have access to the medication. The additional doses will help ensure that high-risk infants have access to the medication.